AI assistant
Sending…
PDS Biotechnology Corp — Director's Dealing 2015
Nov 3, 2015
34613_dirs_2015-11-02_61f1907f-cee8-4c2f-95ab-9606513b9841.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Edge Therapeutics, Inc. (EDGE)
CIK: 0001472091
Period of Report: 2015-10-30
Reporting Person: MIDDLEKAUFF W BRADFORD (Senior VP, GC and Secretary)
More from PDS Biotechnology Corp
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3